Elon Musk's Neuralink gets FDA approval for first in-human brain implant study

Elon Musk’s Neuralink neurotechnology startup company received approval from the U.S. Food and Drug Administration on Thursday to launch its first in-human clinical study.

The company is seeking to develop an implanted brain-computer interface, also called a BCI, that can function outside of a laboratory to assist patients who lose the physical ability to speak.